5.63 USD
↗ 0.25 (4.65%)AT CLOSE (11:59 AM EDT)
Abeona Therapeutics Inc. Common Stock
ABEONASDAQ • USD
5.65
↘ 0.02 (0.28%)
POST MARKET (AS OF 06:33 PM EDT)
Post Market
AS OF 06:33 PM EDT
5.65
↘ 0.02 (0.28%)
Market: OPEN
Open?$5.42
High?$5.67
Low?$5.40
Prev. Close?$5.38
Volume?1.0M
Avg. Volume?1.4M
VWAP?$5.57
Rel. Volume?0.77x
Bid / Ask
Bid?$5.54 × 100
Ask?$5.70 × 100
Spread?$0.16
Midpoint?$5.62
Valuation & Ratios
Market Cap?306.9M
Shares Out?57.0M
Float?48.1M
Float %?88.8%
P/E Ratio?4.31
P/B Ratio?1.93
EPS?$1.25
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?6.93Strong
Quick Ratio?6.74Strong
Cash Ratio?2.65Strong
Debt/Equity?0.13Low
ValuationFAIRLY VALUED
Score73/100
P/E?4.3CHEAP▾
P/B?1.93CHEAP▾
P/S?52.74HIGH▾
P/FCF?N/A▾
EV/EBITDA?-2.9CHEAP▾
EV/Sales?42.70HIGH▾
Returns & Efficiency
ROE?44.7%STRONG▾
ROA?32.4%STRONG▾
Cash Flow & Enterprise
FCF?$-84301000
Enterprise Value?$248.5M
News
Profile
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.
Employees
226
Market Cap
306.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
1980-09-19
Address
6555 CARNEGIE AVE, 4TH FLOOR
CLEVELAND, OH 44103
Phone: 646-813-4701
CLEVELAND, OH 44103
Phone: 646-813-4701